Proper determination of agonist efficacy is essential in the assessment of agonist selectivity and signalling bias. Agonist efficacy is a relative term that is dependent on the system in which it is measured, especially being dependent on receptor expression level. The operational model (OM) of functional receptor agonism is a useful means for the determination of agonist functional efficacy using the maximal response to agonist and ratio of agonist functional potency to its equilibrium dissociation constant (K A ) at the active state of the receptor. However, the functional efficacy parameter τ is interdependent on two other parameters of OM; agonist's K A and the highest response that could be evoked in the system by any stimulus (E MAX ). Thus, fitting of OM to functional response data is a tricky process. In this work we analyse pitfalls of fitting OM to experimental data and propose a rigorous fitting procedure where K A and e MAX are derived from half-efficient concentration of agonist and apparent maximal responses obtained from a series of functional response curves. Subsequently, OM with fixed K A and e MAX is fitted to functional response data to obtain τ. The procedure was verified at M 2 and M 4 muscarinic receptors fused with the G 15 G-protein α-subunit. The procedure, however, is applicable to any receptor-effector system.
Results
Evaluation of the theoretical operational model. The operational model of agonism (OM) is described by following equation:
is the concentration of an agonist, E MAX is the maximal response of the system, K A is the equilibrium dissociation constant of the agonist-receptor complex and τ is the operational factor of efficacy. As can be seen, all 3 parameters (E MAX , K A and τ) are bound. Clearly, the asymptote of the response curve is given by a product of τ and E MAX . Thus, an increase in τ is associated with lowering E MAX and vice versa. Similarly, the inflection point of the response curve is given by the ratio of K A to τ; thus, higher values of τ are accompanied by a corresponding increase in K A , and vice versa. To evaluate the impact of parameter interdependence on non-linear regression, simulated data of theoretical agonists were generated (see Supplementary information) and the OM was fitted to the simulated data by various procedures. Simulated data of functional response to agonist with 1 μM affinity (K A ) were generated by calculation of functional response according to the OM Eq. (1) at 13 concentrations ranging from 0.1 nM to 0.1 mM and addition of 3% of noise ( Fig. 1, left) . Five sets of simulated data were calculated for 5 values of τ, ranging from 0.1 (Fig. 1 , black) to 1000 ( Fig. 1, cyan) with 10-fold increase in each step. Fitting of the OM to individual datasets resulted in a large error margin of calculated parameters (Table 1) . Calculated parameters were correct (close to the simulated ones) only when initial parameter estimates were set to simulated values. When initial parameter estimates were under-or overestimated the calculated parameters were wrong (different Simulated data for an agonist with log K A = −6.0 in 5 systems with coupling efficacy τ varying from 0.1 (black circles) to 1000 (cyan circles). Concentration-response curves were fitted to the simulated data according to Eq. (1). Right: Resulting apparent maximal responses (E' MAX ) were plotted against resulting half-efficient concentrations (EC 50 ). Maximal possible response of the system (E MAX ) and affinity of agonist for receptor (K A ) were obtained by fitting Eq. (6) . Calculated E MAX and K A were used in fitting OM Eq. (1) to the data in the left graph (yellow lines). Resulting τ are in Table 3 .
www.nature.com/scientificreports www.nature.com/scientificreports/ from simulated ones) (Supplementary information, Fig. SI1 ). Specifically, a low initial estimate of E MAX resulted in overestimated τ and high initial estimate of E MAX resulted in underestimated τ in most cases. This confirms that all 3 parameters of the OM are inter-bound. Under these conditions the error margin is so large that it is impossible to estimate OM parameters from individual fits.
It is a requisite to check the distribution of estimated parameters before proceeding with statistical analysis. In pharmacological calculations, many parameters need to be converted to logarithm to remove skewness. To analyse the distribution of parameter τ, 1000 sets of concentration-response curves were simulated. Equation (1) was fitted to these datasets in two forms, one with parameter τ and another with parameter log(τ) (Supplementary information, Fig. SI2 ). In contrast to previous findings 7 , analysis of τ and log(τ) distribution has shown that whether to use τ or log(τ) in Eq. (1) is irrelevant.
As simulated data are for the same system they share parameter E MAX . Global fit of all 5 datasets with shared E MAX reduced fit error ( Table 1 ). The standard deviation of E MAX fell down to 1%. However, SD of parameter τ was still several hundreds of % for datasets D and E. As simulated data are modelled for one agonist, K A is a shared parameter of all datasets too. Global fit of all 5 datasets with shared E MAX and K A parameters further reduced fit error, SD of E MAX remained at 1%, SD of K A was 0.09 log unit and SD of operational efficacy τ was lowest for dataset B (8.5%) and gradually increased with changes in τ value in both directions up to 24%. This confirms previous findings showing the necessity to fit the OM simultaneously to at least two concentration-response curves with shared parameters 6 .
In practice, experimenter may determine agonist affinity for the receptor in a different kind of experiments, e.g. radioligand binding. The impact of fixing K A to simulated value is summarized in Table 2 . Fixing K A to a correct value tremendously reduced fit error. For datasets C, D and E with the highest operational efficacy, SD of E MAX was 1% and SD of parameter τ was about 6%. On the other hand, for dataset A with the lowest efficacy, SD of E MAX was 54% and SD of parameter τ was 68%. According to the OM, EC 50 is related to K A according to the following equation.
A 50 According to Eq. (2), higher operational efficacy τ means lower EC 50 , i.e., a greater left-ward shift of EC 50 from K A . Because the accuracy of determination of EC 50 is constant (on a logarithmic scale), the inaccuracy in EC 50 determination represents proportionally greater error in low efficacy systems, where the difference between EC 50 and K A is small. Operational efficacy τ is bound to E MAX . Thus, the proportionally large error in estimation of operational efficacy τ is translated to a large error in estimation of E MAX . Fitting of the OM to all 5 datasets with fixed K A and shared E MAX led to an increase in the τ SD for datasets D and E. Although the increase in SDs after reducing the number of fitted parameters may seem counter-intuitive at first glance, it could be explained by the approach of E' MAX to system E MAX . Moreover, the increase in τ SD for datasets D and E is compensated by the reduction of τ SD for datasets A and B.
Although fixing K A in the model system results in estimates of E MAX and τ that are close to the model values, the fitting procedure is still not robust. This is evidenced by the high SD values of E MAX and τ estimates for dataset A ( Table 2) . When fitting Eq. (1) with fixed K A and shared E MAX , SD of E MAX falls to 1% but SD of parameter τ remains relatively high. Furthermore, to obtain correct K A , the experimenter must replicate the same conditions of functional response assay in the ligand binding assay. This may be technically difficult when functional assay is www.nature.com/scientificreports www.nature.com/scientificreports/ carried out at complicated system that is incompatible with radioligand binding assay. Therefore, we searched for an alternative way to obtain the value of all 3 parameters of the OM without a need to fit equation(s) that contain inter-bound parameters. The apparent maximal response E' MAX observed as the upper asymptote of the functional response curve is given by the following equation.
MAX MAX By rearrangement of Eq. (2), τ can be expressed as follows.
A 50 50 Substitution of τ in Eq. (3) results in:
Apparent maximal response E' MAX and half-efficient concentration EC 50 can be reliably obtained by fitting logistic function (Eq. (10), see Methods) to individual concentration-response curves. After plotting E' MAX versus the corresponding EC 50 , fitting Eq. (6) yields a maximal response of the system (E MAX ) and the equilibrium dissociation constant of the agonist-receptor complex (K A ).
Simulated data ( Fig. 1 , left) were fitted with Eq. (10) and resulting E' MAX values were plotted against corresponding EC 50 values ( Fig. 1, right) . Fitting Eq. (6) to the data yielded system E MAX = 0.98 ± 0.01 and logarithm of the equilibrium dissociation constant of the agonist-receptor complex K A = −5.99 ± 0.01 (parameter estimate ± SD). Subsequently, the OM of functional response Eq. (1) with E MAX fixed to 0.98 and log K A fixed to −5.99 was fitted to simulated data ( Fig. 1, left www.nature.com/scientificreports www.nature.com/scientificreports/ parameter τ ranged from less than 1‰ for dataset A to 6% for dataset D, that is a substantial improvement over fitting of the OM Eq. (1) with shared E MAX and fixed K A (Table 3 vs. Table 2 ). Table 4 ). The expression level ranged from to 0.87 to 11.4 pmol of binding sites per mg of protein for the M 2 _G 15 fusion protein and from to 0.53 to 14.6 pmol of binding sites per mg of protein for the M 4 _G 15 fusion protein, respectively (Table 4 ). Expression level was stable among passages. Expression level had no effect on the equilibrium dissociation constant K D of N-[ 3 H]methylscopolamine ([ 3 H]NMS). Fusion of G-protein to receptor resulted in a slightly lower K D (higher affinity) of [ 3 H]NMS than the wild-type receptor 8 . Inhibition constants K I of carbachol, oxotremorine and pilocarpine, respectively, were determined in competition experiments with 1 nM [ 3 H]NMS. All 3 agonists displayed binding to a single low-affinity site. Expression level had no effect on the equilibrium dissociation constant K I of any of the tested agonists (Table 4 ). 4), large (100 to 1000-fold) differences between K I and half-efficient concentrations (EC 50 ) correspond to large (l00 to 1000) values of τ. According to Eq. (3), for very large values of τ the apparent maximal response E' MAX should be very close to the maximal response of the system E MAX . Therefore, apparent E' MAX should theoretically be the same for all receptor expression levels. Obviously, this is not the case here (Figs 2 and 3 ).
Binding experiments. Five cell lines with various expression levels were chosen from newly established cell lines expressing fusion proteins of muscarinic receptor and the G 15 G-protein. The expression level was determined in saturation binding experiments (
Therefore, a new fitting procedure was employed in which maximal response of the system (E MAX ) and agonist equilibrium dissociation constant (K A ) were determined first and then E MAX and K A values were used in fitting of the OM to the functional response data. Specifically, Eq. (10) was fitted to the data and apparent maximal response (E' MAX ), half-efficient concentration (EC 50 ) and slope factor (nH) were determined. All concentration-response curves displayed nH equal to unity. Expression level affected both E' MAX and EC 50 . Increase in expression level resulted in an increase in E' MAX and a decrease in EC 50 . The magnitude of effects of expression level on functional response at M 2 _G 15 was similar to that at M 4 www.nature.com/scientificreports www.nature.com/scientificreports/ the atypical agonists N-desmethylclozapine and xanomeline. First, Eq. (10) was fitted to individual data sets. After subtraction of basal value, Eq. (6) was fitted to E' MAX versus EC 50 data from all 3 experiments for all agonists to obtain E MAX of the assay. Then Eq. (1) with fixed E MAX was fitted to individual functional responses. In IP X assay, τ values of the agonists carbachol, oxotremorine and pilocarpine were the same as in simultaneous fitting of OM to all five clones where both K A and E MAX were fixed (Figs 2 and 3 ; Tables 5 and 6 ). However, estimates of parameter τ were accompanied by greater SD. In [ 35 S]GTPγS binding and IP X assays the functional response even to the superagonist iperoxo was less than 90% at M 2 _G 15 and less than 80% at M 4 _G 15 . In these assays relative SD of τ was about 10%. In intracellular Ca 2+ mobilisation assay the functional response to iperoxo reached 99% of E MAX . In this assay relative SD of τ ranged from 15 to 34%, being much lower than that in case of direct fitting of OM with shared E MAX . In intracellular Ca 2+ mobilisation assay, agonist ranking by parameter τ was the same as in [ 35 S] GTPγS and IP X assays. Also, the estimates of K A were the same in all assays.
Discussion
Proper determination of agonist efficacy is a cornerstone in the assessment of possible agonist selectivity and signalling bias. Agonist efficacy at a given receptor or receptor subtype is affected by the system in which it is determined. Black and Leff 1 presented a model, termed the operational model of agonism (OM) of receptor-effector systems. In its original principle, the OM is applicable to any receptor effector system. Over time the OM became a golden standard in pharmacological analysis 3, 4 . Extended and modified versions of this model are widely applied, not only to agonist action, but also to allosteric activation and allosteric modulation [10] [11] [12] [13] [14] or to analyse agonist signalling bias at GPCRs 15-18 as well as non-GPCRs 19 . Table 5 . Parameters of functional response of fusion protein of M 2 muscarinic receptor and G 15 G-protein in CHO cell lines. Maximal response of the system (E MAX ) and equilibrium dissociation constant of the agonistreceptor complex (K A ) were calculated by fitting Eq. (6) to E' MAX versus EC 50 plot in Fig. 2 . The operational factor of efficacy (τ) was obtained by fitting Eq. (1) with fixed parameters E MAX and K A to concentration response curves in Fig. 2 . Data are means ± SD from 3 independent experiments performed in quadruplicates.
www.nature.com/scientificreports www.nature.com/scientificreports/ In the present work we explored potential pitfalls of application of the original OM to fit experimental data. We present a simple procedure for reliable fitting of the OM to experimental data. The procedure divides actual fitting of OM to two steps. Individual steps have lower number of degrees of freedom and thus result in more Table 6 . Parameters of functional response of fusion protein of M 4 muscarinic receptor and G 15 G-protein in CHO cell lines. Maximal response of the system (E MAX ) and equilibrium dissociation constant of the agonistreceptor complex (K A ) were calculated by fitting Eq. (6) to E' MAX versus EC 50 plot in Fig. 3 . The operational factor of efficacy (τ) was obtained by fitting Eq. (1) with fixed parameters E MAX and K A to concentration response curves in Fig. 3 . Data are means ± SD from 3 independent experiments performed in quadruplicates. Table 7 . Data are means ± SD from 3 independent experiments.
www.nature.com/scientificreports www.nature.com/scientificreports/ reliable parameter estimates. We demonstrate usefulness of this procedure in a system where the affinity of the agonist for the receptor in active state cannot be reliably determined in binding experiments and also in a system where the functional response to the agonist approaches the maximal response of the system.
Response to an agonist is affected by the system, mainly by the expression level of the receptor. Mass action law dictates that the relationship between occupancy and effect must be hyperbolic. Therefore, response to agonist according to the OM is described by Eq. (1) , where E MAX is the maximal response of the system, K A is the agonist equilibrium dissociation constant at the receptor in an active conformation and τ is the operational efficacy 1 . All 3 parameters (E MAX , K A and τ) of Eq. (1) are inter-bound and thus Eq. (1) should be fitted to at least two concentration-response curves with shared parameters 6 . The asymptote of the response curve is given by the product of τ and E MAX and inflection point is given by the ratio of K A to τ. Thus, K A is also inter-bound to E MAX via τ. Functions with inter-bound parameters generally have flat curvature of sum of error function that prevents finding its global minimum and estimation of fitted parameters is therefore associated with large error margins. This was confirmed by fitting of Eq. (1) to individual response curves of the theoretical model system (Fig. 1, Tables 1 and 2) . Moreover, result of fit (parameter estimates) is influenced by initial values of fitted parameters ( Supplementary  Information, Fig. SI1 ). Further analysis of the theoretical model system showed that major improvement of fit is achieved by fixing K A value while performing global fit with shared E MAX . Thus, precise determination of K A turns to be corner stone in application of the OM. However, in contrast to previous findings 7 , analysis of parameter τ distribution was independent of whether τ or log(τ) is used (Supplementary information, Fig. SI2 ).
Experimental conditions (like temperature, ionic strength, solution composition, receptor environment) affect agonist K A . Thus, when K A is determined in different kinds of experiment (e.g. radioligand binding assay), conditions of the assay have to strictly mimic those in functional assay. In this case, K A should be determined at www.nature.com/scientificreports www.nature.com/scientificreports/ whole cells attached to the bottom of 96-well plate. In whole cells, agonists display low-affinity binding that is the result of negative cooperativity between binding of GDP and binding of an agonist to the receptor G-protein complex 20 . K A is the ratio between the experimentally calculated low-affinity K I and factor of binding cooperativity of GDP and agonist. As far as the factor of binding cooperativity is unknown, K A cannot be calculated. In membranes, muscarinic agonists usually display both high-and low-affinity binding 21 as free GDP is removed and bound GDP partly dissociates during membrane preparation. At the M 2 _G 15 and M 4 _G 15 fusion proteins, however, inhibition of [ 3 H]NMS binding by tested agonists showed only low-affinity binding ( Table 4 ). It is possible that at constructed fusion proteins interaction of G-protein with the receptor in an inactive conformation is very strong and that GDP is locked in its binding site at G-protein 22 . The locking precludes dissociation of GDP from the G-protein. An open question remains, namely whether K I of agonist high-affinity binding observed in membranes can be taken as K A . Actually, K A may be affected by many factors including binding cooperativity between agonist and GDP-less G-protein and by changes resulting from membrane preparation. Taking this into account, it may be actually safer to determine K A from a series of functional experiments according to the procedure described below than to determine K A in radioligand binding assays.
Indeed, inhibition constants K I of low-affinity agonist binding were too high to be considered as K A . Considering that K A equals K I ( Supplementary Information, Figs SI3-SI8 ) resulted in high values of τ as a result of high K A to EC 50 ratio (Eq, d). For high values of τ apparent maximal response E' MAX approximates maximal response of the system E MAX (Eq. (3) ). Thus variation in E' MAX caused variation in E MAX . However, E MAX should be the same for all 5 cell clones. Global fit of Eq. (1) to functional response data in all 5 cell clones with shared E' MAX did not converge ( Supplementary Information, Figs SI3-SI8, yellow dotted lines) .
Therefore, a novel procedure to obtain reliable values of K A and E MAX by meta-analysis of functional response data was developed. Analysis of the OM according to Eq. (1) shows that the apparent maximal response E' MAX relates to the maximal response of the system E MAX according to Eq. (3) and EC 50 relates to K A according to Eq. (4). E' MAX and EC 50 were obtained by fitting Eq. (10) to data of individual functional responses (Figs 2 and 3 , left and right upper and left lower plots, full lines). Subsequently, E' MAX values were taken as a function of Table 7 . Parameters of functional response of M 2 _G 15 fusion protein to muscarinic agonists. Eq. (10) was fitted to individual data sets. Eq. (6) was fitted to E' MAX versus EC 50 data from all 3 experiments for all agonists to obtain E MAX of the assay. Equation (1) with fixed E MAX was fitted to individual functional responses. Data are means ± SD from 3 independent experiments. Table 8 . Parameters of functional response of M 4 _G 15 fusion protein to muscarinic agonists. Equation (10) was fitted to individual data sets. Equation (6) was fitted to E' MAX versus EC 50 data from all 3 experiments for all agonists to obtain E MAX of the assay. Equation (1) with fixed E MAX was fitted to individual functional responses. Data are means ± SD from 3 independent experiments.
Regardless the number of systems employed, the procedure is limited to conditions with substantially different τ values ranging from 0.1 to 100. The procedure will not work when only agonists with τ greater than 100 are available as K A could not be properly estimated using Eq. (6) . Such situation should be resolved experimentally by reduction of receptor number using an irreversible antagonist that will bring τ values down to allow K A determination. Similarly, if only very weak agonists with τ lower than 0.1 are available, then the procedure will not work either as system E MAX could not be properly estimated using Eq. (6) . In such case, a highly efficacious agonist needs to be added for comparison. Measurements of intracellular Ca 2+ (Figs 4 and 5 , Tables 7 and 8) show that our procedure can be used in a system where E' MAX of agonists approaches E MAX of the system; a case where direct fitting of OM would be problematic.
In principle, the procedure described above can be used everywhere OM is applicable including other G-protein coupled receptors or any receptor-effector system in general 1, 2 . Moreover, the procedure can also be applied to all possible variants of the OM as far as relations between parameters of the OM variant and parameters of classical (e.g. logistic) function can be established. For example, introducing the slope factor (Hill coefficient) to Eq. (1) does not change the relation of EC 50 to K A and E' MAX to E MAX as slope factor cancels out itself in Eqs (2) and (3).
Conclusions
Described two-step analysis of functional response represents the robust way of fitting operational model of agonism (OM) to experimental data. Although our procedure was developed using muscarinic acetylcholine receptors as a test system, it is in principle applicable to any receptor-effector system where OM is used. Also, the procedure can be applied to all possible variants of the OM as far as relations between parameters of the OM variant and parameters of classical (e.g. logistic) function can be established. We believe the procedure will have significant practical value in the proper ranking of agonists efficacies in various systems. Cell culture and membrane preparation. CHO cells were grown to confluence in 75 cm 2 flasks in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum. Two million cells were subcultured in 100-mm Petri dishes. The medium was supplemented with 5 mM sodium butyrate for the last 24 hours of cultivation to increase receptor expression. Cells were washed with phosphate-buffered saline and manually harvested on day 5 after subculture and centrifuged for 3 min at 250 × g. The pellet was suspended in 10 ml of ice-cold homogenization medium (100 mM NaCl, 20 mM Na-HEPES, 10 mM EDTA, pH = 7.4) and homogenized on ice by two 30 sec strokes using a Polytron homogenizer (Ultra-Turrax; Janke & Kunkel GmbH & Co. KG, IKA-Labortechnik, Staufen, Germany) with a 30-sec pause between strokes. Cell homogenates were centrifuged for 5 min at 1000 × g. The supernatant was collected and centrifuged for 30 min at 30,000 × g. Pellets were suspended in the washing medium (100 mM, 10 mM MgCl 2 , 20 mM Na-HEPES, pH = 7.4), left for 30 min at 4 °C, and then centrifuged again for 30 min at 30,000 × g. Resulting membrane pellets were kept at −80 °C until assayed.
Methods
Radioligand binding experiments. All radioligand binding experiments were optimized and carried out according to general guidelines 23 Microfluorometry of free intracellular calcium. Cells grown on glass coverslips were washed twice with KHB and then prelabelled with 5 µM Fura 2-AM in KHB enriched with 1 mM pluronic P68 for one hour at 37 °C. After prelabelling cells were washed twice with KHB, mounted to a superfusion chamber, placed on a stage of Olympus IX-90 inverted fluorescent microscope, and continuously superfused at a flow rate 0.5 ml/min. Microfluorometry was set-up to measure kinetics of the functional response to agonists. Cells expressing fusion proteins of muscarinic receptors and G 15 G-protein were exposed to 5 increrasing concentrations of agonist for 10 s. Individual exposures were separated by 10 min superfusion with agonist-free KHB medium. Images were recorded using a CCD camera connected to a computer equipped with Metafluor 7.0 software (Visitron Systems GmBH, Germany) for image acquisition and analysis. Images of the whole measured field containing about 40 cells were saved and analysed off-line after the measurements. Two pairs of images per second were recorded. Only responding cells were selected (by exclusion of weakly and/or slow responding cells or cells with abnormal response; the outliers in peak value, time to peak or fall time were identified by interquartile range (IQR) where data below Q1-1.5*IQR and above Q3 + 1.5*IQR were considered outliers) for further analysis. Calcium signals of selected cells were averaged, normalized to basal calcium level and further analysed by means of array-oriented program Grace (http://plasma-gate.weizmann.ac.il/Grace).
Generation and analysis of theoretical data. Whole processes of the theoretical data generation, non-linear regression and analysis of the results were automated by scripts written in Python 2.7. Theoretical data with 3% of proportional noise were simulated by NumPy package. Non-linear regression was performed using optimize function of SciPy package. Standard deviations of estimated parameters were calculated from Jacobian covariance matrix. For control the standard deviations were computed by bootstrap method. Data and fits were visualized by Matplotlib package.
Analysis of experimental data.
Data from experiments were processed in Libre Office and then analyzed and plotted using program Grace (http://plasma-gate.weizmann.ac.il/Grace). Statistical analysis was performed using statistical package R (http://www.R-project.org). The following equations were used for non-linear regression analysis: where y is specific radioligand binding at concentration x of competitor expressed as per cent of binding in the absence of competitor, IC 50 is the concentration causing 50% inhibition of radioligand binding at high (IC 50high ) and low (IC 50low ) affinity binding sites, f low is the fraction of low affinity binding sites expressed in per cent. Inhibition constant K I was calculated as: where y is response normalized to basal activity at concentration x, E' MAX is apparent maximal response, EC 50 is concentration causing half-maximal effect, and nH is Hill coefficient.
